Stocktoria
SANUWAVE Health, Inc. SNWV
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2008-11-07
SANUWAVE Health, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.1M | $32.6M | $20.4M | $16.7M | $13.0M | $4.1M | $1.5M | $1.9M | $738,527 | $1.4M |
| Gross profit | $34.0M | $24.6M | $14.4M | $12.4M | $8.0M | $2.9M | $489,807 | $1.2M | $496,557 | — |
| R&D expense | $1.4M | $673,000 | $579,000 | $567,000 | $1.1M | $1.2M | $1.2M | $981,654 | $1.3M | $1.1M |
| Operating income | $4.9M | $3.8M | -$540,000 | -$9.0M | -$14.1M | -$25.2M | -$8.8M | -$7.2M | -$3.8M | -$3.3M |
| Interest expense | — | — | — | — | — | — | $1.8M | $4.5M | $1.1M | $854,980 |
| Income tax | $86,000 | $27,000 | $4,000 | $2,000 | $28,000 | $0 | $0 | $0 | $0 | $0 |
| Net income | $11.8M | -$33.1M | -$25.8M | -$10.3M | -$27.3M | -$30.9M | -$10.4M | -$11.6M | -$5.5M | -$6.4M |
| EPS (diluted) | $0.41 | $-7.41 | $-12.19 | $-0.02 | $-0.05 | $-0.08 | $-0.05 | — | — | — |
| Operating cash flow | $3.9M | $2.5M | -$4.5M | -$17.2M | -$6.4M | -$12.7M | -$6.4M | -$3.6M | -$1.5M | -$3.2M |
| Free cash flow | $1.9M | $2.0M | -$4.5M | — | -$6.9M | -$12.8M | -$6.5M | -$3.7M | -$1.5M | -$3.2M |
| Cash & equivalents | $12.0M | $10.2M | $1.8M | $1.2M | $619,000 | $2.4M | $1.8M | $364,549 | $730,184 | $133,571 |
| Inventory | $5.9M | $4.1M | $3.0M | $868,000 | $1.0M | $3.0M | $542,955 | $357,820 | $231,532 | $231,953 |
| Total assets | $37.3M | $30.1M | $22.4M | $19.9M | $18.6M | $23.0M | $3.4M | $1.2M | $1.3M | $1.0M |
| Total liabilities | $35.7M | $45.9M | $65.6M | $60.9M | $57.6M | $36.7M | $13.4M | $16.5M | $11.2M | $7.9M |
| Shareholders' equity | $1.6M | -$15.8M | -$44.5M | -$41.0M | -$39.0M | -$13.7M | -$10.1M | -$15.4M | -$9.9M | -$6.9M |
Growth · year-over-year · Revenue CAGR 47%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +35.0% | +60.0% | +21.8% | +28.7% | +220.7% | +165.4% | -17.4% | +150.5% | -46.3% | +42.5% |
| Free cash flow growth | -1.6% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.